This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Chairman's Letter To Stockholders, Customers, Employees And Friends: Michael J. Birck To Retire After 2013 Annual Stockholders Meeting

NAPERVILLE, Ill., Aug. 24, 2012 /PRNewswire/ --

Dear Stockholders, Customers, Employees and Friends,

For over 35 years, Tellabs has been a very major part of my life.  We have experienced many joys and a few difficult times, and we worked together to respond to a fair number of challenges.  This year has been particularly difficult.  Cancer took Rob Pullen from us much too soon.  We lost a dear friend and colleague, something that makes one stop and think about the big issues.

I am not getting any younger, and with advancing years often come health issues.  I have had a few of those, but I recently learned that I have chronic myelomonocytic leukemia.  CMML, as it is called, is a relatively uncommon form of bone marrow cancer that is most often diagnosed in folks over 60.  It is treatable, but it is not curable.  I have started treatment, which includes a series of chemotherapy sessions and frequent blood tests.  I feel good, but I understand that this is something I must expect to live with from now on.

I have occasionally thought of the day when I would step down as Chairman and fully retire from Tellabs.  I had not reached that decision until now.  Today I advised our Board that I will not seek re-election to the Board of Directors at our Annual Meeting next spring, and that I will retire at that time.  Until then, however, I will be actively engaged with our Board and our talented management team in leading Tellabs forward in this challenging industry.  Dealing with CMML will be just one more challenge in the process.

Leading Tellabs has been an incredibly rewarding experience for me, and I thank each and every one of you for being a part of that experience. 

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,826.30 -279.47 -1.54%
S&P 500 2,081.18 -23.81 -1.13%
NASDAQ 4,931.8150 -75.9760 -1.52%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs